Oren B, Raz R, Hefter H, Kennes Y, Potasman I
Infectious Disease Unit, Central Emek Hospital, Afula.
Harefuah. 1991 Jan 15;120(2):60-2.
Urinary tract infections (UTI), especially in women, are very frequent and require antimicrobial treatment. The choice of drug depends on the susceptibility of the infecting organism. In many cases treatment is begun before the identity and susceptibility of the organism/s cultured are known. Knowledge of the profile of the infecting organisms and their drug susceptibility can improve the treatment of community-acquired UTI. We recorded the distribution and susceptibility of 50,699 positive UTI cultures, during the years 1986-7, in 2 community laboratories in northern Israel serving a population of about 830,000. The sensitivity of organisms to ampicillin was only 32 in the Haifa region and 42 in the Afula region and, respectively, to cotrimoxazole 51 and 76, to cephalexin 60 and 77, to nitrofurantoin 83 and 89, and to nalidixic acid 80 and 92. The differences between the regions were statistically significant. As a result of this study, we suggest that ampicillin should not be used empirically in UTI in these these 2 regions, nor cotrimoxazole in the Haifa region. All women with uncomplicated UTI should be treated with nitrofurantoin or nalidixic acid, provided they are not sensitive to these drugs and tolerate them well. The use of new drugs such as the quinolones and amoxicillin/clavulanic acid must be controlled and monitored to avoid rapid development of resistant strains.
尿路感染(UTI),尤其是女性的尿路感染非常常见,需要进行抗菌治疗。药物的选择取决于感染病原体的敏感性。在许多情况下,在培养出的病原体的身份和敏感性明确之前就开始治疗。了解感染病原体的情况及其药物敏感性有助于改善社区获得性尿路感染的治疗。我们记录了1986年至1987年期间,以色列北部两个社区实验室中50699份尿路感染阳性培养物的分布情况及其药敏结果,这两个实验室服务的人口约为83万。在海法地区,病原体对氨苄西林的敏感性仅为32%,在阿富拉地区为42%;对复方新诺明的敏感性分别为51%和76%;对头孢氨苄的敏感性分别为60%和77%;对呋喃妥因的敏感性分别为83%和89%;对萘啶酸的敏感性分别为80%和92%。两个地区之间的差异具有统计学意义。根据这项研究结果,我们建议在这两个地区的尿路感染中不应凭经验使用氨苄西林,在海法地区也不应使用复方新诺明。所有无并发症的尿路感染女性患者,只要对呋喃妥因或萘啶酸不敏感且耐受性良好,均应以这两种药物治疗。喹诺酮类和阿莫西林/克拉维酸等新药的使用必须加以控制和监测,以避免耐药菌株的迅速出现。